Clinical Trials · NCT01931982
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Bispebjerg Hospital
- Enrollment
- 20
- Start date
- May 2013
- Locations
- 1 site, Denmark
- Primary endpoint
- Change in coronary flow reserve (CFR)